TY - JOUR T1 - Effects of Methylphenidate Discontinuation on Cerebral Blood Flow in Prepubescent Boys with Attention Deficit Hyperactivity Disorder JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1624 LP - 1629 VL - 43 IS - 12 AU - Daniel D. Langleben AU - Paul D. Acton AU - Glenn Austin AU - Igor Elman AU - Gary Krikorian AU - John R. Monterosso AU - Orith Portnoy AU - Hugh W. Ridlehuber AU - H. William Strauss Y1 - 2002/12/01 UR - http://jnm.snmjournals.org/content/43/12/1624.abstract N2 - Methylphenidate (MPH) is an effective symptomatic treatment of attention deficit hyperactivity disorder (ADHD), but the mechanisms of its therapeutic action have not been fully elucidated. To address this issue, we assessed the effects of discontinuation of chronic MPH treatment on regional cerebral blood flow (rCBF) in ADHD patients. Methods: Twenty-two prepubescent boys with ADHD (age range, 8.2–11.5 y) and 7 healthy volunteers were studied with SPECT on and off MPH. Their rCBF data were automatically normalized to whole-brain counts and coregistered with standard anatomic space. rCBF changes were evaluated with statistical parametric mapping based on voxel-by-voxel ANOVA. Results: When the subjects were not taking MPH, rCBF was higher in the motor, premotor, and the anterior cingulate cortices (Brodmann’s areas 4, 6, and 32). Conclusion: Brief discontinuation of MPH treatment is associated with increased motor and anterior cingulate cortical activity. Our findings suggest that MPH treatment modulates motor and anterior cingulate cortical activity directly or indirectly. Alternatively, our findings may be related to MPH withdrawal. These data provide novel information on the potential mechanisms of the therapeutic action of MPH. Furthermore, they are clinically relevant to the commonly occurring brief interruptions in MPH treatment. ER -